[Therapy of obstructive respiratory tract diseases. I: Beta 2-sympathomimetic drugs and anticholinergic agents (m-cholinergic receptor blockers)].
Ukena
D
D
Schlimmer
P
P
Sybrecht
G W
GW
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000403:Airway Resistance / Q000187:drug effects; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D009130:Muscle, Smooth / Q000294:innervation; D010276:Parasympatholytics / Q000627:therapeutic use*; D011943:Receptors, Adrenergic, beta / Q000187:drug effects; D011976:Receptors, Muscarinic / Q000187:drug effects
D000318:Adrenergic beta-Agonists; D010276:Parasympatholytics; D011943:Receptors, Adrenergic, beta; D011976:Receptors, Muscarinic
Die Therapie obstruktiver Atemwegserkrankungen. Teil I: Beta 2-Sympathomimetika und Anticholinergika (m-Cholinozeptoren-Blocker).